Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 4/20 | 0.63 |
| ▸ | HPGD | P15428 | 4/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.63 |
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.63 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | HPGDS | O60760 | 1/20 | 0.42 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.41 |
| ▸ | AKR1C2 | P52895 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cliprofen SCHEMBL11702737 | 1.00 | PTGS1 (0.63) | PTGS1HPGDALDH1A1CYP2C9LMNA | |
| Cliprofen SCHEMBL29910028 | 1.00 | PTGS1 (0.63) | PTGS1HPGDALDH1A1CYP2C9LMNA | |
| SCHEMBL11706148 | 0.86 | HPGD (0.46) | PTGS1HPGDALDH1A1CYP2C9LMNA | |
| SCHEMBL11703127 | 0.85 | PTGS1 (0.68) | PTGS1HPGDALDH1A1CYP2C9LMNA | |
| SCHEMBL11703120 | 0.85 | PTGS1 (0.68) | PTGS1HPGDALDH1A1CYP2C9LMNA | |
| SCHEMBL11703609 | 0.85 | SMN1; SMN2 (0.46) | PTGS1HPGDALDH1A1CYP2C9LMNA | |
| SCHEMBL11702059 | 0.84 | HPGD (0.50) | PTGS1HPGDALDH1A1CYP2C9LMNA | |
| SCHEMBL11707683 | 0.81 | HPGD (0.42) | PTGS1HPGDALDH1A1CYP2C9LMNA | |
| SCHEMBL11707677 | 0.81 | HPGD (0.42) | PTGS1HPGDALDH1A1CYP2C9LMNA | |
| SCHEMBL11727367 | 0.81 | GAA (0.44) | PTGS1HPGDALDH1A1CYP2C9LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2838 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4335413-A2 | PROSTHETIC TISSUE VALVES | Cormatrix Cardiovascular, Inc. (US) | 2024-03-13 | — | — | EP | claimed |
| WO-2023212179-A2 | THERAPEUTIC COMPOSITIONS FOR SKIN DISORDERS AND WOUND REPAIR | UNIVERSITY OF MIAMI (US) | 2023-11-02 | — | — | WO | claimed |
| US-20220110979-A1 | FIBROBLAST REGENERATIVE CELLS | FIGENE, LLC | 2022-04-14 | — | — | US | claimed |
| EP-3908297-A1 | FIBROBLAST REGENERATIVE CELLS | Figene, LLC (US) | 2021-11-17 | — | — | EP | claimed |
| EP-3279663-B1 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | BRIGHAM & WOMENS HOSPITAL INC (US) | 2021-07-28 | — | — | EP | claimed |
| WO-2020146874-A1 | FIBROBLAST REGENERATIVE CELLS | FIGENE, LLC (US) | 2020-07-16 | — | — | WO | claimed |
| EP-3279663-A1 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | The Brigham and Women's Hospital, Inc. (US) | 2018-02-07 | — | — | EP | claimed |
| US-20170281724-A9 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2017-10-05 | — | — | US | claimed |
| EP-2001496-B1 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | BRIGHAM & WOMENS HOSPITAL INC (US) | 2017-05-31 | — | — | EP | claimed |
| US-20160228505-A1 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2016-08-11 | — | — | US | claimed |
| CN-1284863-A | Topical compositions for NSAI drug delivery | NEXMED HOLDINGS INC (US) | 2001-02-21 | — | — | CN | claimed |
| EP-1003501-A4 | MEANS OF ASCERTAINING AN INDIVIDUAL'S RISK PROFILE FOR ATHEROSCLEROTIC DISEASE | BRIGHAM & WOMENS HOSPITAL (US) | 2001-01-17 | — | — | EP | claimed |
| EP-1028710-A1 | TOPICAL COMPOSITIONS FOR NSAI DRUG DELIVERY | Nexmed Holdings, Inc. (US) | 2000-08-23 | — | — | EP | claimed |
| US-6083996-A | COMPRISES ONE OR MORE NON-STEROID ANTIINFLAMMATORY AGENT, A NON-BASIC POLYMERIC SKIN PENETRATION ENHANCER AND A LIPOPHILIC SOLVENT CONTAINING ALIPHATIC ALCOHOL AND ALIPHATIC ESTER MIXTURE | NEXMED HOLDINGS, INC. (US) | 2000-07-04 | — | — | US | claimed |
| EP-1003501-A1 | MEANS OF ASCERTAINING AN INDIVIDUAL'S RISK PROFILE FOR ATHEROSCLEROTIC DISEASE | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2000-05-31 | — | — | EP | claimed |
| WO-1999022716-A1 | TOPICAL COMPOSITIONS FOR NSAI DRUG DELIVERY | NEXMED HOLDINGS, INC. (US) | 1999-05-14 | — | — | WO | claimed |
| WO-1998043630-A1 | MEANS OF ASCERTAINING AN INDIVIDUAL'S RISK PROFILE FOR ATHEROSCLEROTIC DISEASE | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 1998-10-08 | — | — | WO | claimed |
| EP-0466650-A2 | Improvements in non-steroidal anti-inflammatory therapy | WARNER-LAMBERT COMPANY (US) | 1992-01-15 | — | — | EP | claimed |
| US-4185100-A | CORTICOSTEROID AND A HYDROTROPIC ACID DERIVATIVE, ENZYME INHIBITORS | JOHNSON & JOHNSON (US) | 1980-01-22 | — | — | US | claimed |
| US-4035376-A | ESTERS, AMIDES, HYDROXAMIC ACIDS, ANTIINFLAMMATORY | JANSSEN PHARMACEUTICA N.V. (BE) | 1977-07-12 | — | — | US | claimed |